[Journal logo]

Volume 66 
Part 6 
Page o1309  
June 2010  

Received 5 April 2010
Accepted 14 April 2010
Online 12 May 2010

Key indicators
Single-crystal X-ray study
T = 293 K
Mean [sigma](C-C) = 0.003 Å
Disorder in main residue
R = 0.047
wR = 0.133
Data-to-parameter ratio = 16.2
Details
Open access

4-[(Z)-Allylamino(phenyl)methylene]-3-methyl-1-phenyl-1H-pyrazol-5(4H)-one

aCollege of Chemistry, Tianjin Normal University, 393 Binshuixi Road, Xiqing District, Tianjin 300387, People's Republic of China,bNankai High School, 100 Sima Road, Nankai District, Tianjin 300100, People's Republic of China, and cState Key Laboratory of Elemento-Organic Chemistry, Nankai University, Tianjin 300071, People's Republic of China
Correspondence e-mail: hsxyxhz@mail.tjnu.edu.cn, zyq8165@nankai.edu.cn

The title compound, C20H19N3O, exists in a keto-enamine tautomeric form. The pyrazolone ring makes dihedral angles of 20.52 (10) and 77.73 (5)° with the two phenyl rings and an intramolecular N-H...O hydrogen bond occurs. A weak intermolecular C-H...O hydrogen bond is observed in the crystal structure. The allyl group is disordered over two positions, with site-occupancy factors of 0.533 (5) and 0.467 (5).

Related literature

For the analgesic activity of metal complexes with 1-phenyl-3-methyl-4-benzoylpyrazolon-5-one, see: Li et al. (1997[Li, J.-Z., Yu, W.-J. & Du, X.-Y. (1997). Chin. J. Appl. Chem. 14, 98-100.]); Liu et al. (1980[Liu, J.-M., Yang, R.-D. & Ma, T.-R. (1980). Chem. J. Chin. Univ. 1, 23-29.]); Zhou et al. (1999[Zhou, Y.-P., Yang, Zh.-Y., Yu, H.-J. & Yang, R.-D. (1999). Chin. J. Appl. Chem. 16, 37-41.]). For related structures, see: Bao et al. (2004[Bao, F., Lü, X.-Q., Qiao, Y.-Q., Wu, Q. & Ng, S. W. (2004). Acta Cryst. E60, o2191-o2192.]); Sun et al. (2007[Sun, Y.-F., Li, J.-K., Wu, R.-T. & Zheng, Z.-B. (2007). Acta Cryst. E63, o2176-o2177.]); Zhu et al. (2005[Zhu, H., Zhang, X., Song, Y., Xu, H. & Dong, M. (2005). Acta Cryst. E61, o2387-o2388.]).

[Scheme 1]

Experimental

Crystal data
  • C20H19N3O

  • Mr = 317.38

  • Triclinic, [P \overline 1]

  • a = 9.295 (1) Å

  • b = 9.8440 (12) Å

  • c = 10.0670 (14) Å

  • [alpha] = 86.175 (8)°

  • [beta] = 89.280 (9)°

  • [gamma] = 74.329 (7)°

  • V = 884.90 (19) Å3

  • Z = 2

  • Mo K[alpha] radiation

  • [mu] = 0.08 mm-1

  • T = 293 K

  • 0.22 × 0.18 × 0.16 mm

Data collection
  • Rigaku Saturn724 CCD camera diffractometer

  • Absorption correction: multi-scan (CrystalClear; Rigaku, 2009[Rigaku (2009). CrystalClear and CrystalStrcuture. Rigaku Corporation, Tokyo, Japan.]) Tmin = 0.984, Tmax = 0.988

  • 10726 measured reflections

  • 3910 independent reflections

  • 2135 reflections with I > 2[sigma](I)

  • Rint = 0.032

Refinement
  • R[F2 > 2[sigma](F2)] = 0.047

  • wR(F2) = 0.133

  • S = 0.94

  • 3910 reflections

  • 242 parameters

  • 16 restraints

  • H atoms treated by a mixture of independent and constrained refinement

  • [Delta][rho]max = 0.17 e Å-3

  • [Delta][rho]min = -0.19 e Å-3

Table 1
Hydrogen-bond geometry (Å, °)

D-H...A D-H H...A D...A D-H...A
N3-H3...O1 1.06 (2) 1.75 (2) 2.687 (2) 145 (2)
C17-H17...O1i 0.95 2.41 3.345 (2) 168
Symmetry code: (i) -x, -y+2, -z+2.

Data collection: CrystalClear (Rigaku, 2009[Rigaku (2009). CrystalClear and CrystalStrcuture. Rigaku Corporation, Tokyo, Japan.]); cell refinement: CrystalClear; data reduction: CrystalClear; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); molecular graphics: CrystalStructure (Rigaku, 2009[Rigaku (2009). CrystalClear and CrystalStrcuture. Rigaku Corporation, Tokyo, Japan.]); software used to prepare material for publication: CrystalStructure.


Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: IS2538 ).


Acknowledgements

The authors gratefully acknowledge the financial support of the National Natural Science Foundation of China (grant No. 20772066).

References

Bao, F., Lü, X.-Q., Qiao, Y.-Q., Wu, Q. & Ng, S. W. (2004). Acta Cryst. E60, o2191-o2192.  [CSD] [CrossRef] [details]
Li, J.-Z., Yu, W.-J. & Du, X.-Y. (1997). Chin. J. Appl. Chem. 14, 98-100.  [ChemPort]
Liu, J.-M., Yang, R.-D. & Ma, T.-R. (1980). Chem. J. Chin. Univ. 1, 23-29.  [ChemPort]
Rigaku (2009). CrystalClear and CrystalStrcuture. Rigaku Corporation, Tokyo, Japan.
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.  [CrossRef] [details]
Sun, Y.-F., Li, J.-K., Wu, R.-T. & Zheng, Z.-B. (2007). Acta Cryst. E63, o2176-o2177.  [CrossRef] [details]
Zhou, Y.-P., Yang, Zh.-Y., Yu, H.-J. & Yang, R.-D. (1999). Chin. J. Appl. Chem. 16, 37-41.  [ChemPort]
Zhu, H., Zhang, X., Song, Y., Xu, H. & Dong, M. (2005). Acta Cryst. E61, o2387-o2388.  [CSD] [CrossRef] [details]


Acta Cryst (2010). E66, o1309  [ doi:10.1107/S160053681001384X ]

This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.